Eversight Connecticut Vision | Page 7

Changing Times A recipient’s decades-long journey to sight John Ruggiero has seen a lot in 71 years. But something he never imagined was the day when his sight would be restored in just a matter of hours. John lived with vision problems since he was a teenager, but it wasn’t until his 20s that he realized how poor his eyesight had become. “I was enlisting in the Reserve Officers’ Training Corps (ROTC) program, and during my physical the doctor said with eyesight like mine I’d be dead in six months,” John recalled. John was diagnosed with keratoconus, a progressive eye disease that causes the cornea to thin and become cone-shaped, resulting in distorted vision. In 1969 treatments for keratoconus were limited, but a relatively new operation – a cornea transplant – offered some hope for restoring John’s sight. John was placed on a waiting list and, after several months, received a transplant. The recovery was long and arduous. He spent 25 hours under anesthesia, followed by 11 days in the hospital laying flat on his back, motionless with his eyes closed. Then came two weeks at home before he could finally return to work. 1990s Surgeons and researchers begin to develop new transplant and tissue preparation techniques that offer vastly improved outcomes for more patients. In 1997, the FDA begins regulating eye banks to reduce transmission of communicable diseases and ensure tissue safety. The cornea transplant waiting list is virtually eliminated by the growing support for eye donation. 2000s Specialized transplant procedures using only a portion of the cornea are refined and introduced into clinical practice launching the modern era of transplantation. The techniques significantly improve the recovery and transplant process, and outcomes for many patients. In 2006, Eversight begins offering tissue preparation services to meet the growing demand for these Spring 2016 | V I S I O N | Page new7procedures. While the surgery was considered a success, the results were fair at best, John said, leaving him with 20/100 vision. But he took it all in stride. “You have to pick yourself up, dust yourself off and move on. Live life like anyone else,” John said. And he did just that – starting a family, raising three children and building a successful career. But the degenerative nature of keratoconus brought John a lifetime of treatments to improve his vision including numerous eyeglass and contact lens prescriptions, refractive and cataract surgeries, and many more transplants. The most recent transplant truly opened John’s eyes to a new world. In January of last year, he scheduled his sixth cornea transplant. This latest experience was far different than the first: John arrived at the surgical center at 10 in the morning and was back home by 1:30 that afternoon. Even more astounding is that John now has nearly perfect 20/20 vision. “If someone had told me after my first transplant experience that one day I’d be home just hours after surgery, I would have never believed them,” John said. “I have better vision now at 71 than I did when I was 30!” Looking to the Future 2010s Eversight expands fullservice tissue processing for new treatment options. In partnership with experienced transplant surgeons, Eversight launches a training program to teach the next group of surgeons the latest transplant techniques for their patients. Eversight partners with surgeons and researchers to find new ways to treat corneal blindness through improved transplant techniques, cell therapies, bionic technologies and more. Spring 2016 | V I S I O N | Page 7